Immunogenicity of Ribosomal Vaccines Isolated from Group A, Type 14 Streptococcus pyogenes

A ribosomal preparation isolated from group A, type 14 Streptococcus pyogenes protected mice against a challenge of 1,000 mean lethal doses. Optimal immunization consisted of subcutaneous administration of 326 μg of protein with Freund incomplete adjuvant. Animals immunized with higher or lower anti...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Infect Immun
Principais autores:	Schalla, W. O., Johnson, W.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1975
Assuntos:	Immunology
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC415199/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/806521/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.11.6.1195-1202.1975
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!